Related references
Note: Only part of the references are listed.Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders
Dennis D. Arnold et al.
FRONTIERS IN IMMUNOLOGY (2022)
The role of interleukin-1 family members in hyperuricemia and gout
Viola Kluck et al.
JOINT BONE SPINE (2021)
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATOLOGY (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares
Augustin Latourte et al.
JOINT BONE SPINE (2020)
2020 American College of Rheumatology Guideline for the Management of Gout
John D. FitzGerald et al.
ARTHRITIS CARE & RESEARCH (2020)
Use of Anakinra in Hospitalized Patients with Crystal-associated Arthritis
Jean W. Liew et al.
JOURNAL OF RHEUMATOLOGY (2019)
Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial
Carly A. Janssen et al.
RHEUMATOLOGY (2019)
Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016
Michael Chen-Xu et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Difficult-to-treat rheumatoid arthritis: an area of unmet clinical need
Maria J. H. de Hair et al.
RHEUMATOLOGY (2018)
Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels
Daniel H. Solomon et al.
ANNALS OF INTERNAL MEDICINE (2018)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The British Society for Rheumatology Guideline for the Management of Gout
Michelle Hui et al.
RHEUMATOLOGY (2017)
What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions
Sophi Tatlock et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2017)
Efficacy of Canakinumab vs. triamcinolone acetonide according to multiple gouty arthritis-related health outcomes measures
J. D. Hirsch et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
OMERACT Endorsement of Measures of Outcome for Studies of Acute Gout
Jasvinder A. Singh et al.
JOURNAL OF RHEUMATOLOGY (2014)
Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
John S. Sundy et al.
JOURNAL OF RHEUMATOLOGY (2014)
Treatment of acute gout: A systematic review
Puja P. Khanna et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Anti-Interleukin-1 Therapy in the Management of Gout
Naomi Schlesinger
CURRENT RHEUMATOLOGY REPORTS (2014)
Interleukin-1 inhibitors for acute gout
Francisca Sivera et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
Essack Mitha et al.
RHEUMATOLOGY (2013)
Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients With Anakinra
Pradipta Ghosh et al.
ARTHRITIS CARE & RESEARCH (2013)
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
Sebastien Ottaviani et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
Robert A. Terkeltaub et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial
H. Ralph Schumacher et al.
ARTHRITIS AND RHEUMATISM (2012)
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
H. Ralph Schumacher et al.
ARTHRITIS CARE & RESEARCH (2012)
Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
Robert T. Keenan et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1 beta-mediated diseases
Alexander M. Owyang et al.
MABS (2011)
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
Naomi Schlesinger et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Interleukin-1 Antagonism in Acute Gout: Is Targeting a Single Cytokine the Answer?
Tuhina Neogi
ARTHRITIS AND RHEUMATISM (2010)
Canakinumab for the Treatment of Acute Flares in Difficult-to-Treat Gouty Arthritis Results of a Multicenter, Phase II, Dose-Ranging Study
Alexander So et al.
ARTHRITIS AND RHEUMATISM (2010)
Diagnosing and Treating Gout: A Review to Aid Primary Care Physicians
Naomi Schlesinger
POSTGRADUATE MEDICINE (2010)
Anakinra's Efficacy is Variable in Refractory Gout: Report of Ten Cases
Kun Chen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
R. Terkeltaub et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Share Paper
